HC

Helena Chaye

Chief Executive Officer

KaliVir Immunotherapeutics

San Francisco, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
KaliVir Immunotherapeutics
Industry
research
Employees
44.0
Seniority
C suite
Annual Revenue
3500000.0
Latest Funding
Series A

Technologies

Outlook Microsoft Office 365 GoDaddy Hosting Google Font API Mobile Friendly WordPress.org Vimeo Varnish Remote

Keywords

biotechnology research oncolytic viral immunotherapy cancer treatment vet backbone technology systemic delivery chemokine receptors therapeutic payload tumor targeting clinical trials immune response biopharmaceutical gene therapy tumor microenvironment anti-tumor immunity fda clearance investigational new drug biotechnology novel oncolytic viruses tumor types clinical operations cancer vaccines drug development biomedical engineering immuno-oncology biotech industry regulatory affairs biologics therapeutics pipeline preclinical data phase i trials phase iii studies regulatory negotiations strategic partnerships innovative therapies tumor immunophenotypes scientific evaluation patient outcomes research team vaccine therapy clinical development pre-ind biotechnology leadership growth equity funding therapeutic efficacy iv delivery vehicles viral replication tumor environment modification anticancer therapies clinical efficacy health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans